Event

PSI Conference Webinar: Retire Statistical Significance (!) (?) - How do we know what we know?

Add to:

Sponsored by AstraZeneca Logo

Date: Wednesday 10th June 2020     

Time: 14:30 - 16:00
Chair: Stephen Ruberg (Analytix Thinking)
Speaker: Ron Wasserstein (ASA) & Deborah Ashby (RSS & Imperial College)

Registration:

This webinar is part of our 2020 Conference Webinar Series. Further information including details of other webinars that are included in the Conference package can be found here.
Members receive all webinars in the conference series for free.
Non-members receive all webinars in the conference series for £100+VAT, which includes complimentary membership* of PSI until the 31st December 2020. 

To register your place for this event, and others in the Conference webinar series, please click here.

Session Abstract:

Inferring what is likely to be true based statistical analysis of data is a very difficult task and certainly not as easy as computing a p-value for declaring H0 to be true or false based on an arbitrary cut-off value. Much has been written over the last eight decades on hypothesis testing, p-values, Bayesian inference with the conversations (or sometimes acrimonious debate) continuing. This session will include the leaders from the two most prominent statistical societies in the world –The Royal Statistical Society (Deborah Ashby) and the American Statistical Association (Ron Wasserstein) –and moderated by Stephen Ruberg. Listen to their perspectives and sharpen your statistical thinking.

Speaker Details:

 Chair  Biography
SteRubcropped
Stephen Ruberg

Analytix Thinking
 Stephen J. Ruberg, PhDis President of Analytix Thinking, LLC, a consulting company focused on strategic and technical consulting for drug development as well as teaching statistical concepts to non-statisticians. Previously, Dr. Ruberg was a Distinguished Research Fellow and Scientific Leader, Advanced Analytics, Eli Lilly & Company. He is also Adjunct Professor of Statistics at Purdue University. In the pharmaceutical industry since 1981, he has been an industry leader in the development and application of statistical methods in drug development as well as advances in data management and eClinical technology. He has published widely in statistical, scientific, and industry trade journals and is a frequent speaker at statistical and scientific conferences. Among other awards and recognitions, in 1994, he was elected a Fellow of the American Statistical Association (ASA) and in 2012 received the Career Achievement Award from Quantitative Scientists in the Pharmaceutical Industry (QSPI). He was elected a Fellow of the International Statistics Institute (ISI) in 2018. Dr. Ruberg was Deputy Chair for the ICH Expert Working Group that published the ICH-E9 document Statistical Principles for Clinical Trials. He received the FDA Commissioner’s Special Citation for his work on electronic NDAs. He was on the Executive Committee of the ASA Biopharmaceutical Section and was Chair of the PhRMA Biostatistics and Data Management Steering Committee. He was the first Chairman of the Board of Directors for the Clinical Data Interchange Standards Consortium (CDISC)and was actively involved with CDISC for its first seven years. In the past, he served as Chair of the Board of Trustees of the Mathematical Biosciences Institute at The Ohio State University, and was appointed by the Secretary of Health and Human Services (HHS) to the board of directors for the National eHealth Collaborative, which was working to create the US Nationwide Health Information Network. Dr. Ruberg received a BA in Mathematics from Thomas More College, an MS in Statistics from Miami University in Ohio, and a PhD in Biostatistics from the University of Cincinnati.

Speaker

Biography

RonWasscropped
Ron Wasserstein,
ASA

Ronald L. (Ron) Wasserstein is the executive director of the American Statistical Association (ASA). Wasserstein assumed the ASA’s top staff leadership post in August 2007. In this role, Wasserstein provides executive leadership and management for the association and is responsible for ensuring that the ASA fulfils its mission to promote the practice and profession of statistics. He also is responsible for a staff of 35 at the ASA’s headquarters in Alexandria, Va. As executive director, Wasserstein also is an official ASA spokesperson.

Prior to joining the ASA, Wasserstein was a mathematics and statistics department faculty member and administrator at Washburn University in Topeka, Kan., from 1984–2007. During his last seven years at the school, he served as the university’s vice president for academic affairs. Wasserstein is a long-time member of the ASA, having joined the association in 1983, and has been active as a volunteer in the ASA for more than 20 years. He twice served as president of the Kansas-Western Missouri Chapter of the ASA. Wasserstein served as chair of two ASA sections—the ASA Section on Statistical Education and the ASA Section on Statistical Consulting. He also chaired the Council of Chapters Governing Board in 2006 and was a member of the ASA Board of Directors from 2001–2003. Wasserstein is a Fellow of the ASA and American Association for the Advancement of Science. He was presented the John Ritchie Alumni Award and Muriel Clarke Student Life Award from Washburn University and the ManningDistinguished Service Award from the North American Association of Summer Schools.

DebAshcropped
Deborah Ashby,
RSS & Imperial College

Professor Deborah Ashby is Director of the School of Public Health at Imperial College London where she holds the Chair in Medical Statistics and Clinical Trials and was Founding Co-Director of Imperial Clinical Trials Unit. She is a Chartered Statistician and her research interests are in clinical trials, risk-benefit decision making for medicines, and the utility of Bayesian approaches in these areas. She is currently President of the Royal Statistical Society. She has sat on the UK Commission on Human Medicines and acts as adviser to the European Medicines Agency. She has recently chaired the Population Research Committee for Cancer Research UK and the National Institute for Health Research HTA Commissioning Board and was Deputy Chair of the HTA Programme. Deborah was awarded the OBE for services to medicine in 2009, appointed an NIHR Senior Investigator in 2010, and elected to the Academy of Medical Sciences in 2012.

Upcoming Events

Latest Jobs